These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38487143)

  • 41. Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997-2019.
    Peñuelas M; Guerrero-Vadillo M; Valdezate S; Zamora MJ; Leon-Gomez I; Flores-Cuéllar Á; Carrasco G; Díaz-García O; Varela C
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The First Reported Case of Infant Botulism in Korea: Treatable Infantile Neuromuscular Disease.
    Jang HG; Jang J; Jung HJ; Jung DE
    J Korean Med Sci; 2020 Apr; 35(14):e93. PubMed ID: 32281313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual herpetic reactivation in a young female following botox injection: a case report study.
    Amini-Salehi E; Eslami N; Tamimi A; Sedighi N; Moghdam SS; Yaghubi-Kalurazi T; Hassanipour S; Joukar F; Mansour-Ghanaei F; Eftekhari H
    BMC Infect Dis; 2023 Oct; 23(1):647. PubMed ID: 37784014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Botulism: Diagnosis and Therapy].
    Wendt S; Eder I; Wölfel R; Braun P; Lippmann N; Rodloff A
    Dtsch Med Wochenschr; 2017 Sep; 142(17):1304-1312. PubMed ID: 28850968
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.
    Yu PA; Lin NH; Mahon BE; Sobel J; Yu Y; Mody RK; Gu W; Clements J; Kim HJ; Rao AK
    Clin Infect Dis; 2017 Dec; 66(suppl_1):S57-S64. PubMed ID: 29293928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.
    Hatheway CH; Snyder JD; Seals JE; Edell TA; Lewis GE
    J Infect Dis; 1984 Sep; 150(3):407-12. PubMed ID: 6481185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulism: the challenge of diagnosis and treatment.
    Brook I
    Rev Neurol Dis; 2006; 3(4):182-9. PubMed ID: 17224901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Botulism: A case report and literature review].
    Gendrot M; Passeron A; Michon A; Pouchot J
    Rev Med Interne; 2020 Jul; 41(7):485-488. PubMed ID: 32061395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Practice of botulism].
    Ikeguchi K
    Brain Nerve; 2011 Jul; 63(7):763-73. PubMed ID: 21747147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulism in the Brazilian Amazon: a life-threatening disease in a neglected population.
    Oliveira LM; Gonçalves DB; Cabral LCR; Bernardino MRA; Feitoza PVS
    Arq Neuropsiquiatr; 2022 Dec; 80(12):1227-1232. PubMed ID: 36580960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostic difficulties in foodborne botulism--case reports and literature review].
    Chwaluk P; Chwaluk A
    Przegl Lek; 2007; 64(4-5):348-51. PubMed ID: 17724910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New targets in the search for preventive and therapeutic agents for botulism.
    Anniballi F; Lonati D; Fiore A; Auricchio B; De Medici D; Locatelli CA
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1075-86. PubMed ID: 25089560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Iatrogenic botulism: a complication to be taken into account in the treatment of child spasticity].
    Beseler-Soto B; Sánchez-Palomares M; Santos-Serrano L; Landa-Rivera L; Sanantonio-Valdearcos F; Paricio-Talayero JM
    Rev Neurol; 2003 Sep 1-15; 37(5):444-6. PubMed ID: 14533094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Botox phenomenon.
    Darlington AB
    Plast Surg Nurs; 2010; 30(1):22-6; quiz 27-8. PubMed ID: 20220495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulism mimicking Guillain-Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis.
    Silva Campos JJ; Abels E; Rinder HM; Tormey CA; Jacobs JW
    J Clin Apher; 2023 Dec; 38(6):760-763. PubMed ID: 37519071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
    Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
    PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Food-borne botulism].
    Nakamura Y; Sawada M; Ikeguchi K; Nakano I
    Brain Nerve; 2011 Sep; 63(9):979-85. PubMed ID: 21878700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.
    Tacket CO; Shandera WX; Mann JM; Hargrett NT; Blake PA
    Am J Med; 1984 May; 76(5):794-8. PubMed ID: 6720725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Foodborne botulism presenting as small bowel obstruction: a case report.
    Friziero A; Sperti C; Da Dalt G; Baldan N; Zanchettin G; Auricchio P; Gavagna L; Grego A; Capelli G; Merigliano S
    BMC Infect Dis; 2021 Jan; 21(1):55. PubMed ID: 33435866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lambert-Eaton Myasthenic Syndrome, Botulism, and Immune Checkpoint Inhibitor-Related Myasthenia Gravis.
    Guidon AC
    Continuum (Minneap Minn); 2019 Dec; 25(6):1785-1806. PubMed ID: 31794471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.